Humanetics, Unigen Present New Research at Weight-loss Conference

Humanetics, Unigen Present New Research at Weight-loss Conference

WASHINGTONHumanetics Corp.and Unigen Pharmaceuticals presented new research on their branded weight-lossingredients at the Second Annual World Obesity and Weight Loss Congress.

John Zenk, M.D., chief medical officer of Humanetics,presented a case study on 3-acetyl-7-oxodehydroepiandrosterone (patented as7-Keto®), a metabolite of dehydroepiandrosterone (DHEA). According to the newresearch, titled Naturally Enhanced Weight Loss Supported by Science, 7-Keto produces three times greater weight loss than diet andexercise alone, and increases metabolism.

I think it is a testament to our track record of methodicaland rigorous clinical investigation that 7-Keto was chosen as a case study,said John Dykstra, chief operating officer (COO) of Humanetics. We willpresent what we believe to be the most significant clinical substantiation ofboth safety and efficacy for any dietary ingredient in the weight loss marketspace.

Qi Jia, Ph.D., chief scientific officer of Unigen, presentedresults of new research surrounding the companys ingredient UP120, a novelcomposition of free-B-ring flavonoids and flavans derived from Scutellaria andAcacia plants, designed to help people shed pounds and maintain a healthy weightby influencing fructose metabolism and cytokine production. Jia also discussedthe companys PhytoLogix® technology platform, which includes anethno-medicinal plant library of more than 5,900 medicinal plants, 6,500 plantextracts and 120,000 fractions; and its role in the discovery and development ofUP120.

This conference provided a perfect forum for Unigen toshare research progress with peer scientists in the industry on the developmentof natural weight management ingredients resulting from Unigens novel andpatentpending discovery and screening platform, Jia said. Obesity hasskyrocketed these past few years, where it is estimated that approximatelytwo-thirds of American adults are overweight or obese, along with an alarmingnumber of children and teens as well. This is of particular concern, sinceobesity leads to many other serious health conditions, such as Type II diabetes.Unigen joins the charge of many other leading research and development companiesand finished goods manufacturers to create exciting new health products thataddress this important concern.

For more information on Humanetics, visitwww.humaneticscorp.com or Booth #3054-3056 at SupplySide West; for additionalinformation on Unigen, visit www.unigen.com or Booth #5001 at SupplySide West.